{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:07:31Z","timestamp":1778720851379,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"value":"9781071650554","type":"print"},{"value":"9781071650561","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5056-1_15","type":"book-chapter","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:07:55Z","timestamp":1778717275000},"page":"157-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Chemotactic Effects of MIF on Neutrophils and T Cells and Methods for Selective Receptor Targeting"],"prefix":"10.1007","author":[{"given":"Zhishen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aphrodite","family":"Kapurniotu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","volume":"3","author":"T Calandra","year":"2003","unstructured":"Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791\u2013800","journal-title":"Nat Rev Immunol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fmed.2019.00003","volume":"6","author":"A Kapurniotu","year":"2019","unstructured":"Kapurniotu A, Gokce O, Bernhagen J (2019) The multitasking potential of alarmins and atypical chemokines. Front Med 6:3","journal-title":"Front Med"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nm1567","volume":"13","author":"J Bernhagen","year":"2007","unstructured":"Bernhagen J, Krohn R, Lue H et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587\u2013596","journal-title":"Nat Med"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng L, Metz CN, Fang Y et al (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467\u20131476","journal-title":"J Exp Med"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1073\/pnas.56.1.72","volume":"56","author":"JR David","year":"1966","unstructured":"David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72\u201377","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","volume":"25","author":"X Shi","year":"2006","unstructured":"Shi X, Leng L, Wang T et al (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595\u2013606","journal-title":"Immunity"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1096\/fj.15-273904","volume":"29","author":"S Alampour-Rajabi","year":"2015","unstructured":"Alampour-Rajabi S, El Bounkari O, Rot A et al (2015) MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis. FASEB J 29:4497\u20134511","journal-title":"FASEB J"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","volume":"583","author":"V Schwartz","year":"2009","unstructured":"Schwartz V, Lue H, Kraemer S et al (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett 583:2749\u20132757","journal-title":"FEBS Lett"},{"key":"15_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57540-z","volume":"16","author":"O El Bounkari","year":"2025","unstructured":"El Bounkari O, Zan C, Yang B et al (2025) An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis. Nat Commun 16: 2297","journal-title":"Nat Commun"},{"key":"15_CR10","doi-asserted-by":"crossref","unstructured":"Tilstam PV, Schulte W, Holowka T et al (2021) MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model. J Clin Invest 131:e127171","DOI":"10.1172\/JCI127171"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1021\/bi982184o","volume":"38","author":"H Sugimoto","year":"1999","unstructured":"Sugimoto H, Taniguchi M, Nakagawa A et al (1999) Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. Biochemistry 38:3268\u20133279","journal-title":"Biochemistry"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s44161-023-00295-x","volume":"2","author":"L Dib","year":"2023","unstructured":"Dib L, Koneva LA, Edsfeldt A et al (2023) Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complications. Nat Cardiovasc Res 2:656\u2013672","journal-title":"Nat Cardiovasc Res"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00018-024-05338-5","volume":"81","author":"L Zhang","year":"2024","unstructured":"Zhang L, Woltering I, Holzner M et al (2024) CD74 is a functional MIF receptor on activated CD4(+) T cells. Cell Mol Life Sci 81:296","journal-title":"Cell Mol Life Sci"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9936-1_1","volume":"2080","author":"A Hoffmann","year":"2020","unstructured":"Hoffmann A, Zwissler LC, El Bounkari O et al (2020) Studying the Pro-Migratory Effects of MIF. Methods Mol Biol 2080:1\u201318","journal-title":"Methods Mol Biol"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1038\/s41467-020-19764-z","volume":"11","author":"C Kontos","year":"2020","unstructured":"Kontos C, El Bounkari O, Krammer C et al (2020) Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. Nat Commun 11:5981\u20135981","journal-title":"Nat Commun"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"eadg2621","DOI":"10.1126\/scisignal.adg2621","volume":"16","author":"L Spiller","year":"2023","unstructured":"Spiller L, Manjula R, Leissing F et al (2023) Plant MDL proteins synergize with the cytokine MIF at CXCR2 and CXCR4 receptors in human cells. Sci Signal 16:eadg2621","journal-title":"Sci Signal"}],"container-title":["Methods in Molecular Biology","Macrophage Migration Inhibitory Factor"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5056-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:07:56Z","timestamp":1778717276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5056-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650554","9781071650561"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5056-1_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"J.B., and A.K. are co-inventors of a patent application covering MIF-binding CXCR4 ectodomain mimics for inflammatory and cardiovascular diseases. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}